Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1943 1
1957 2
1959 2
1960 1
1961 1
1962 6
1964 4
1965 4
1966 14
1967 8
1968 10
1969 3
1970 9
1971 2
1972 1
1973 3
1974 9
1975 3
1976 4
1977 5
1978 3
1979 4
1980 6
1981 7
1982 7
1983 1
1984 2
1985 4
1986 5
1987 4
1988 5
1989 3
1990 8
1991 5
1992 3
1993 5
1994 2
1995 1
1996 7
1997 1
1998 5
1999 5
2000 8
2001 5
2002 11
2003 12
2004 7
2005 11
2006 4
2007 8
2008 5
2009 5
2010 5
2011 6
2012 11
2013 20
2014 28
2015 19
2016 25
2017 22
2018 26
2019 18
2020 51
2021 56
2022 37
2023 36
2024 22

Text availability

Article attribute

Article type

Publication date

Search Results

597 results

Results by year

Filters applied: . Clear all
Page 1
The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease.
Wallace ZS, Naden RP, Chari S, Choi H, Della-Torre E, Dicaire JF, Hart PA, Inoue D, Kawano M, Khosroshahi A, Kubota K, Lanzillotta M, Okazaki K, Perugino CA, Sharma A, Saeki T, Sekiguchi H, Schleinitz N, Stone JR, Takahashi N, Umehara H, Webster G, Zen Y, Stone JH; American College of Rheumatology/European League Against Rheumatism IgG4-Related Disease Classification Criteria Working Group. Wallace ZS, et al. Among authors: della torre e. Arthritis Rheumatol. 2020 Jan;72(1):7-19. doi: 10.1002/art.41120. Epub 2019 Dec 2. Arthritis Rheumatol. 2020. PMID: 31793250
The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease.
Wallace ZS, Naden RP, Chari S, Choi HK, Della-Torre E, Dicaire JF, Hart PA, Inoue D, Kawano M, Khosroshahi A, Lanzillotta M, Okazaki K, Perugino CA, Sharma A, Saeki T, Schleinitz N, Takahashi N, Umehara H, Zen Y, Stone JH; Members of the ACR/EULAR IgG4-RD Classification Criteria Working Group. Wallace ZS, et al. Among authors: della torre e. Ann Rheum Dis. 2020 Jan;79(1):77-87. doi: 10.1136/annrheumdis-2019-216561. Epub 2019 Dec 3. Ann Rheum Dis. 2020. PMID: 31796497 Review.
International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease.
Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers MN, Chari ST, Della-Torre E, Frulloni L, Goto H, Hart PA, Kamisawa T, Kawa S, Kawano M, Kim MH, Kodama Y, Kubota K, Lerch MM, Löhr M, Masaki Y, Matsui S, Mimori T, Nakamura S, Nakazawa T, Ohara H, Okazaki K, Ryu JH, Saeki T, Schleinitz N, Shimatsu A, Shimosegawa T, Takahashi H, Takahira M, Tanaka A, Topazian M, Umehara H, Webster GJ, Witzig TE, Yamamoto M, Zhang W, Chiba T, Stone JH; Second International Symposium on IgG4-Related Disease. Khosroshahi A, et al. Among authors: della torre e. Arthritis Rheumatol. 2015 Jul;67(7):1688-99. doi: 10.1002/art.39132. Arthritis Rheumatol. 2015. PMID: 25809420 Review. No abstract available.
Development of an algorithm for IgG4-related disease management.
Orozco-Gálvez O, Fernández-Codina A, Lanzillotta M, Ebbo M, Schleinitz N, Culver EL, Rebours V, D'Cruz DP, Della-Torre E, Martínez-Valle F. Orozco-Gálvez O, et al. Among authors: della torre e. Autoimmun Rev. 2023 Mar;22(3):103273. doi: 10.1016/j.autrev.2023.103273. Epub 2023 Jan 20. Autoimmun Rev. 2023. PMID: 36682575 Review.
European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations.
Löhr JM, Beuers U, Vujasinovic M, Alvaro D, Frøkjær JB, Buttgereit F, Capurso G, Culver EL, de-Madaria E, Della-Torre E, Detlefsen S, Dominguez-Muñoz E, Czubkowski P, Ewald N, Frulloni L, Gubergrits N, Duman DG, Hackert T, Iglesias-Garcia J, Kartalis N, Laghi A, Lammert F, Lindgren F, Okhlobystin A, Oracz G, Parniczky A, Mucelli RMP, Rebours V, Rosendahl J, Schleinitz N, Schneider A, van Bommel EF, Verbeke CS, Vullierme MP, Witt H; UEG guideline working group. Löhr JM, et al. Among authors: della torre e. United European Gastroenterol J. 2020 Jul;8(6):637-666. doi: 10.1177/2050640620934911. Epub 2020 Jun 18. United European Gastroenterol J. 2020. PMID: 32552502 Free PMC article.
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance.
Shaffer SM, Dunagin MC, Torborg SR, Torre EA, Emert B, Krepler C, Beqiri M, Sproesser K, Brafford PA, Xiao M, Eggan E, Anastopoulos IN, Vargas-Garcia CA, Singh A, Nathanson KL, Herlyn M, Raj A. Shaffer SM, et al. Among authors: torre ea. Nature. 2017 Jun 15;546(7658):431-435. doi: 10.1038/nature22794. Epub 2017 Jun 7. Nature. 2017. PMID: 28607484 Free PMC article.
Fibrotic phenotype of IgG4-related disease.
Lanzillotta M, Culver E, Sharma A, Zen Y, Zhang W, Stone JH, Della-Torre E. Lanzillotta M, et al. Among authors: della torre e. Lancet Rheumatol. 2024 Jul;6(7):e469-e480. doi: 10.1016/S2665-9913(23)00299-0. Epub 2024 Apr 1. Lancet Rheumatol. 2024. PMID: 38574746 Review.
597 results